Potent small molecule inhibitors of spleen tyrosine kinase (Syk)

被引：75

作者：

Lai, JYQ ^{[1
]}

Cox, PJ ^{[1
]}

Patel, R ^{[1
]}

Sadiq, S ^{[1
]}

Aldous, DJ ^{[1
]}

Thurairatnam, S ^{[1
]}

Smith, K ^{[1
]}

Wheeler, D ^{[1
]}

Jagpal, S ^{[1
]}

Parveen, S ^{[1
]}

Fenton, G ^{[1
]}

Harrison, TKP ^{[1
]}

McCarthy, C ^{[1
]}

Bamborough, P ^{[1
]}

机构：

[1] Aventis Pharmaceut, Bridgewater, NJ 08807 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 18期

关键词：

D O I：

10.1016/S0960-894X(03)00658-9

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of oxindoles demonstrating inhibition of the pbosphorylation of biotinylated substrates of Syk and IgE/FcepsilonRI triggered basophil cell degranulation has been identified. A study of the SAR around sulfonamide 31 (IC50=5 nM, EC50= 1400 nM) is discussed. The modest cellular activity representative of the sulfonamide series was overcome when the Polar surface Area was lowered to < 110 Angstrom(2), leading to the identification of amide 32 (IC50= 145 nM, EC50= 100 nM). (C) 2003 Published by Elsevier Ltd.

引用

收藏

页码：3111 / 3114

页数：4

相关论文

共 50 条

[41] Heart failure associated with small molecule tyrosine kinase inhibitors [J].

Imran, Tasnim F. ;

Shah, Rashesh ;

Ha, Albert S. ;

Thomas, Renjit ;

Joseph, Jacob .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 206 :110-+

[42] Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors [J].

Choi, Jang-Sik ;

Hwang, Hae-jun ;

Kim, Se-Won ;

Lee, Byung Il ;

Lee, Jaekyoo ;

Song, Ho-Juhn ;

Koh, Jong Sung ;

Kim, Jung-Ho ;

Lee, Phil Ho .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (20) :4441-4446

[43] Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy [J].

Cheng Liao ;

Jonathan Hsu ;

Yong Kim ;

Dong-Qing Hu ;

Daigen Xu ;

Jun Zhang ;

Achal Pashine ;

John Menke ;

Toni Whittard ;

Natasha Romero ;

Theresa Truitt ;

Michelle Slade ;

Christine Lukacs ;

Johannes Hermann ;

Mingyan Zhou ;

Matthew Lucas ;

Satwant Narula ;

Julie DeMartino ;

Seng-Lai Tan .

Arthritis Research & Therapy, 15

[44] Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy [J].

Liao, Cheng ;

Hsu, Jonathan ;

Kim, Yong ;

Hu, Dong-Qing ;

Xu, Daigen ;

Zhang, Jun ;

Pashine, Achal ;

Menke, John ;

Whittard, Toni ;

Romero, Natasha ;

Truitt, Theresa ;

Slade, Michelle ;

Lukacs, Christine ;

Hermann, Johannes ;

Zhou, Mingyan ;

Lucas, Matthew ;

Narula, Satwant ;

DeMartino, Julie ;

Tan, Seng-Lai .

ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)

[45] The spleen tyrosine kinase (Syk) in human disease, implications for design of tyrosine kinase inhibitor based therapy [J].

Navara, CS .

CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (15) :1739-1744

[46] SPLEEN TYROSINE KINASE (SYK) IS A NOVEL THERAPEUTIC TARGET FOR INTRAHEPATIC CHOLANGIOCARCINOMA [J].

Yuan, Hui ;

Lin, Zelong ;

Liu, Yingjun ;

Weng, Xie ;

Zhou, Yuchen ;

Tu, Mengxian ;

Zheng, Dandan ;

Li, Jinying ;

He, Lu ;

Qu, Chen ;

Wu, Ziqing ;

Hong, Jian .

HEPATOLOGY, 2019, 70 :559A-560A

[47] Activity of spleen tyrosine kinase (Syk) is required for development of colitis in mice [J].

Kraneveld, Aletta ;

Rijnierse, Anneke ;

Herlaar, Ellen ;

Singh, Rajinder ;

Payan, Donald ;

Schmitz, Jochen ;

Bunnett, Nigel W. .

GASTROENTEROLOGY, 2007, 132 (04) :A230-A230

[48] Targeting spleen tyrosine kinase (SYK): structure, mechanisms and drug discovery [J].

Zhang, Shuangqian ;

Wang, Lilin ;

Lu, Yingying ;

Guo, Chuanxin ;

Zhang, Tongtong ;

Zhang, Lan .

DRUG DISCOVERY TODAY, 2025, 30 (01)

[49] ACTIVITY OF SPLEEN TYROSINE KINASE (SYK) IS REQUIRED FOR DEVELOPMENT OF COLITIS IN MICE [J].

Raats, D. ;

Rijnierse, A. ;

Herlaar, E. ;

Singh, R. ;

Payan, D. G. ;

Schmitz, J. ;

Bunnett, N. ;

Kraneveld, A. D. .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (02) :209-210

[50] Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis [J].

Ulanova, M ;

Duta, F ;

Puttagunta, L ;

Schreiber, AD ;

Befus, AD .

EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (05) :901-921

← 1 2 3 4 5 →